Boster Bio Life Science Blog

Discover the latest advances in biomedical research through our monthly spotlight series. Dive into cutting-edge discoveries—from immunotherapies to nanotech innovations—that are redefining life science.
  1. Research Spotlight – April 2020

    Our April edition of Research Spotlight features 10 recent research discoveries from scientists whom Boster has served.

    This month's selected research publications cover disease areas from acute liver injury to hepatocellular carcinoma to silocosis. The papers also investigate pretreatment TRL, ZBP1 biological function, triclocarban exposure, and several other research topics.

    Scroll down to learn more about these new scientific discoveries.

    ...
    Read more
    Research Spotlight – April 2020
  2. Research Spotlight – March 2020

    In our March edition of Research Spotlight, we feature 10 recently published research papers from scientists whom Boster has served.

    Scroll down to learn more about these new scientific discoveries.

    Berberine prevents primary peritoneal adhesion and adhesion reformation by directly inhibiting TIMP-1

    Authors: Liu, X., Wei, Y., Bai, X., Li, M., Li, H., Wang, L., Zhang, S., Li, X., Zhao, T...
    Journal: Acta Pharmaceutica Sinica B

    Peritoneal adhesions are fibrous tissues that tether organs to one another or to the peritoneal wall and represent the major cause of postsurgical morbidity. Enterolysis at repeat surgeries induces adhesion reformation that is more difficult to prevent than primary adhesion. Here we studied the preventive effects of different approaches of berberine...

    Read More

    Cited Boster Product(s): Human TIMP-1 ELISA Kit PicoKine™ (EK0520); Human MMP-3 ELISA Kit PicoKine™ (EK0461); Human MMP-8 ELISA Kit PicoKine™ (EK0464)

    Journal Cover

    Tracing tumorigenesis in a solid tumor model at single-cell resolution

    Authors: Praktiknjo, S.D., Obermayer, B., Zhu, Q., Fang, L., Liu, H., Quinn, H...
    Journal: Nature Communications

    Characterizing the complex composition of solid tumors is fundamental for understanding tumor initiation, progression and metastasis. While patient-derived samples provide valuable insight, they are heterogeneous on multiple molecular levels, and often originate from advanced tumor stages. Here, we use single-cell transcriptome...

    Read More

    Cited Boster Product(s): Anti-Kallikrein 1/KLK1 Antibody (PA1709)

    Journal Cover

    CCL3/CCR1 mediates CD14+CD16− circulating monocyte recruitment in knee osteoarthritis progression

    Authors: Zhao, X., Gu, M., Xu, X., Wen, X., Yang, G., Li, L., Sheng, P., & Meng, F.
    Journal: Osteoarthritis and Cartilage

    Objectives: Monocyte-derived macrophages, as the predominant immune cell type that is increased in inflamed synovium, play a vital role during knee osteoarthritis (KOA) progression. However, the mechanisms underlying the recruitment of circulating monocytes to osteoarthritic knees remain uncertain. Based on previous data obtained from plasma...

    Read More

    Cited Boster Product(s): Human MCP-1 / CCL2 ELISA Kit PicoKine™ (EK0441); Human MIP-1Alpha/CCL3 ELISA Kit PicoKine™ (EK0448); Human CCL4/MIP-1 Beta ELISA Kit PicoKine™ (EK0450)

    Journal Cover

    Farrerol Directly Targets GSK-3β to Activate Nrf2-ARE Pathway and Protect EA.hy926 Cells against Oxidative Stress-Induced Injuries

    Authors: Yan, C., Zhang, X., Miao, J., Yuan, H., Liu, E., Liang, T., & Li , Q.
    Journal: Oxidative Medicine and Cellular Longevity

    Oxidative stress-mediated endothelial injury is considered to be involved in the pathogenesis of various cardiovascular diseases. Farrerol, a typical natural flavanone from the medic

    ...
    Read more
    Research Spotlight – March 2020
  3. Research Spotlight – February 2020

    At Bosterbio, our customers’ research is our priority. Our mission is to help customers achieve their research goals so that they can stay on the cutting edge of research.

    This February, we’d like to feature a selected number of recently published research from the scientists whom Boster has served.

    Scroll down to see 10 research discoveries from different fields.

    ...
    Read more
    Research Spotlight – February 2020
  4. Research Spotlight – March 2019

    The March edition of Research Spotlight features 10 recent research discoveries from scientists whom Boster has served.

    Scientists of this month’s selected research publications investigated several diseases and disorders, such as lung cancer, nasopharynx cancer, alcoholic liver disease, stroke, emphysema, and schizophrenia.

    Among the studies, different cancer treatments are described including preparing chitosan oligosaccharides (COS) as oral nutritional supplements and enhancing dendritic cell-based cancer vaccines with low-dose radiation exposure.

    Scroll down to learn more about these new scientific discoveries.

    Potential Analysis and Preparation of Chitosan Oligosaccharides as Oral Nutritional Supplements of Cancer Adjuvant Therapy

    Authors: Jiang, Z., Li, H., Qiao, J., Yang, Y., Wang, Y., Liu, W., & Han, B.
    Journal: International Journal of Molecular Sciences

    Cancer is considered to have an adverse influence on health around the world. Chitosan, a linear polysaccharide that contains copolymers of β-1-4 linked d-glucosamine and N-acetyl-d-glucosamine un

    ...
    Read more
    Research Spotlight – March 2019
  5. Research Spotlight – February 2019

    Our February edition of Research Spotlight features 10 recent research discoveries from scientists whom Boster has served.

    This month’s selected research publications investigate targets related to a number of cancers, such as osteosarcoma, hepatocellular carcinoma, pancreatic carcinoma, and glioblastoma, and also include studies that examine targets of Parkinson’s disease and type 2 diabetes mellitus.

    Scroll down to learn more about these new scientific discoveries.

    ...
    Read more
    Research Spotlight – February 2019
  6. Research Spotlight - January 2019

    The January edition of Research Spotlight features 10 recent research discoveries from scientists whom Boster has served.

    Scientists of this month’s selected research publications investigate various aspects of several pathways such as the MAPK, Wnt/β-catenin, TGF-β1/Smad3, NF-κB, Akt/mTOR, and AMPK/ULK1 signaling pathways.

    Scroll down to learn more about these new scientific discoveries.

    Luteolin inhibits IL-1β-induced inflammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model

    Authors: Fei, J., Liang, B., Jiang, C., Ni, H., & Wang, L.
    Journal: Biomedicine & Pharmacotherapy

    Osteoarthritis (OA) is a joint disease characterized by inflammation and cartilage degradation. Accumulating evidence has demonstrated that luteolin, a natural flavonoid, has anti-inflammatory and anticatabolic effects. The present study...

    Read More

    Cited Boster Product(s): Rat TNF Alpha PicoKine™ ELISA Kit (EK0526); Rat MMP-2 PicoK

    ...
    Read more
    Research Spotlight - January 2019
  7. Research Spotlight – December 2018

    Our December edition of Research Spotlight features 10 recent research discoveries from scientists whom Boster has served.

    This month’s selected research publications cover disease areas from arthritis to diabetes to Parkinson’s and include studies that examine NK cells and PD-L1 expressions.

    Scroll down to learn more about these new scientific discoveries.

    ...
    Read more
    Research Spotlight – December 2018
  8. Research Spotlight - November 2018

    At Boster, our customers’ research is our priority. Our mission is to help customers achieve their research goals so that they can stay on the cutting edge of research.

    This November, we’d like to feature a selected number of recently published research from the scientists whom Boster has served. Scroll down to see 10 research discoveries from different fields.

    ...
    Read more
    Research Spotlight - November 2018